TIAP partners with Amgen to commercialize medical research

Toronto Innovation Acceleration Partners (TIAP) – formerly known as MaRS Innovation- and Amgen are collaborating to jointly fund emerging technologies managed by TIAP on behalf of its Toronto-based member institutions. The two organizations will identify promising medical research conducted by the scientific community of Toronto and will further determine which ones have the potential to disrupt the medical industry. Rafi Hofstein, CEO of TIAP, expects that with Amgen’s philosophical and financial backing, the organization will be able to promote science and innovation reach its potential in the marketplace. Moreover, the joint venture will enrich TIAP’s presence in Canada as well as open up a meaningful dialogue with all stakeholders in the local health care system.

Reference Link: https://www.biospace.com/article/toronto-innovation-acceleration-partners-announces-strategic-partnership-with-amgen/


You may also like

0 thoughts on “TIAP partners with Amgen to commercialize medical research”

LEAVE A REPLY

Your email address will not be published. Required fields are marked *

  • MOST READ
  • MOST RECENT

Survey analysis using Likert scale

By Manuscriptedit - Nov 30,2016

Publication Cycle: An Overview

By Manuscriptedit - Jul 28,2017

Writing an Abstract in MLA Style

By Reenita Patra - May 08,2013

How to use the full stop ?

By Manuscriptedit - Sep 28, 2009

How to use the question mark ?

By Manuscriptedit - Sep 28, 2009

How to use the exclamation mark ?

By Manuscriptedit - Sep 28, 2009

How to use the comma ?

By Manuscriptedit - Sep 28, 2009

Tips